Proceeding contribution from Baroness Evans of Bowes Park (Conservative) in the House of Lords on Monday, 10 July 2017. It occurred during Ministerial statement on G20.
G20
The noble Baroness is absolutely right. We made clear at the summit the imperative to tackle global health threats such as
antimicrobial resistance, that research funding alone will not solve the problem and that we must in parallel develop incentives for pharmaceutical companies to bring new drugs to market. The publication of the G20-commissioned report, Tackling Antimicrobial Resistance, Ensuring Sustainable R&D, means that we have a clear way forward looking to the Argentinian G20 presidency next year and beyond. We will continue to work with our international partners on that. We have also committed £50 million towards a global AMR innovation fund, which will target investment in underinvested areas of research and development.
Secondary information
- Type
- Proceeding contribution
- Reference
- 783 c256
- Session
- 2017-19
- Chamber / Committee
- House of Lords chamber
- Subjects
- Developing countries Women Employment Equality Finance International assistance Iraq Germany Iron and steel Economic growth Dumping Overseas trade New businesses Terrorism Refugees Trade Trade agreements Slavery USA Climate Change Convention Syria EU immigration G20 Islamic State Brexit
- Link
- View this Proceeding contribution on hansard.parliament.uk
Librarians' tools
- Timestamp
- 2023-07-22 09:29:23 +0100
- URI
- http://hansard.intranet.data.parliament.uk/Lords/2017-07-10/17071013000219
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2017-07-10/17071013000219
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2017-07-10/17071013000219